Reddy, Krishna P
- Massachusetts General Hospital · Internal Medicine (investigator's affiliation)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #6,310
- Rising Star
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2016 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$1.4M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#6,310
By linked amount among FY2023 PIs
Earliest Year Loaded
2016
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Reddy, Krishna P as a PI. Multi-PI records show the full award amount for context.
- 5R01AI093269-13R01Contact PINovel Methods to Inform HIV/TB Clinical Trial DevelopmentMassachusetts General Hospital · Internal Medicine (investigator's affiliation)$803.1Kaward amount
- 5R01DA050482-04R01Contact PITobacco Use and Cessation, HIV, and TB in South Africa: Clinical and Economic OutcomesMassachusetts General Hospital · Internal Medicine (investigator's affiliation)$615.1Kaward amount
Award organization
Organizations that administered FY2023 awards listing Reddy, Krishna P as a PI.
FY2023 award administered by Massachusetts General Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2016First NIH AwardMassachusetts General Hospital
- 2018$500K Cumulative Funding
- 2018R01 Grant Holder
- 2020$1M Cumulative Funding
- 2020Entered Top 50% NationallyRanked #3940
- 2020Entered Top 25% NationallyRanked #3940
- 2021$2M Cumulative Funding
- 2023$5M Cumulative Funding